share_log

Daoming Optics&Chemical Co.,Ltd's (SZSE:002632) Largest Shareholders Are Individual Investors Who Were Rewarded as Market Cap Surged CN¥362m Last Week

Daoming Optics&Chemical Co.,Ltd's (SZSE:002632) Largest Shareholders Are Individual Investors Who Were Rewarded as Market Cap Surged CN¥362m Last Week

Daoming Optics&Chemical Co.,Ltd(SZSE:002632)的最大股東是個體投資者,他們在上週市值飆升了3.62億人民幣。
Simply Wall St ·  08/26 18:19

Key Insights

主要見解

  • The considerable ownership by individual investors in Daoming Optics&ChemicalLtd indicates that they collectively have a greater say in management and business strategy
  • 51% of the business is held by the top 5 shareholders
  • Insider ownership in Daoming Optics&ChemicalLtd is 11%
  • 大明光學化學有限公司個別投資者擁有的股權,表明他們在管理和業務策略方面具有更大的發言權。
  • 前五大股東持有公司51%股份
  • 大明光學化學有限公司內部持股比例爲11%。

If you want to know who really controls Daoming Optics&Chemical Co.,Ltd (SZSE:002632), then you'll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie are individual investors with 45% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

如果你想知道誰真正控制大明光學化學股份有限公司(SZSE:002632),那麼你需要看一下它的股份註冊狀況。而持有最多股權的群體就是個別投資者,擁有45%的股權。也就是說,如果股票上漲,該群體將獲益最多(或者在經濟下行時損失最多)。

As a result, individual investors collectively scored the highest last week as the company hit CN¥4.6b market cap following a 8.6% gain in the stock.

作爲結果,在上週公司股價上漲8.6%,達到46億人民幣市值的情況下,個人投資者集體得分最高。

Let's delve deeper into each type of owner of Daoming Optics&ChemicalLtd, beginning with the chart below.

讓我們深入了解道明光學化工有限公司各類所有者,首先從下面的圖表開始。

1724710743512
SZSE:002632 Ownership Breakdown August 26th 2024
SZSE:002632所有權分析 2024年8月26日

What Does The Institutional Ownership Tell Us About Daoming Optics&ChemicalLtd?

機構持股情況告訴我們有關道明光學化工有限公司的什麼?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

機構通常在向自己的投資者報告時會針對一個基準進行衡量,因此一旦某隻股票被納入主要指數,他們通常會更加熱衷於該股票。我們預計大多數公司都會有一些機構在登記簿上,尤其是那些正在增長的公司。

Less than 5% of Daoming Optics&ChemicalLtd is held by institutional investors. This suggests that some funds have the company in their sights, but many have not yet bought shares in it. If the business gets stronger from here, we could see a situation where more institutions are keen to buy. When multiple institutional investors want to buy shares, we often see a rising share price. The past revenue trajectory (shown below) can be an indication of future growth, but there are no guarantees.

道明光學化工有限公司不到5%的股份被機構投資者持有。這表明一些基金正在關注該公司,但許多人尚未購買其股票。如果業務從現在起變得更加強勁,我們可能會看到更多機構渴望購買的情況。當多個機構投資者希望購買股票時,我們經常會看到股價上漲。過去營業收入軌跡(如下所示)可能是未來增長的指標,但並無保證。

1724710745060
SZSE:002632 Earnings and Revenue Growth August 26th 2024
2024年8月26日,SZSE:002632公司的收益和營業收入增長。

Hedge funds don't have many shares in Daoming Optics&ChemicalLtd. The company's largest shareholder is Zhejiang Daoming Investment Co., Ltd., with ownership of 40%. In comparison, the second and third largest shareholders hold about 6.7% and 1.4% of the stock. Note that the second and third-largest shareholders are also Senior Key Executive and Chairman of the Board, respectively, meaning that the company's top shareholders are insiders.

多明光學化工股份有限公司的對沖基金持有很少股份。該公司最大的股東是浙江多明投資有限公司,持股40%。相比之下,第二和第三大股東持有該股的約6.7%和1.4%。值得注意的是,第二和第三大股東也分別是高級主管和董事長,意味着該公司的最大股東均爲內部人士。

On looking further, we found that 51% of the shares are owned by the top 5 shareholders. In other words, these shareholders have a meaningful say in the decisions of the company.

進一步觀察後,我們發現前五大股東擁有該公司51%的股份。換句話說,這些股東在公司的決策中有很大的發言權。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. We're not picking up on any analyst coverage of the stock at the moment, so the company is unlikely to be widely held.

研究公司的機構所有權可以爲您的研究增加價值,但同時調查分析師建議也是很好的做法,以更深入地了解股票的預期表現。我們目前沒有發現任何關於該公司的分析師報道,因此該公司不太可能被廣泛持有。

Insider Ownership Of Daoming Optics&ChemicalLtd

多明光學化工股份有限公司的內部持股情況

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

雖然內部人員的精確定義可能具有主觀性,但幾乎所有人都認爲董事會成員是內部人員。管理層最終向董事會負責。然而,如果經理是創始人或CEO,那麼他們成爲執行董事會成員並不罕見。

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

大多數人認爲內部所有權是積極的,因爲它可以表示董事會與其他股東的利益相一致。但是,在某些場合下,這個團體的權力過於集中。

Our information suggests that insiders maintain a significant holding in Daoming Optics&Chemical Co.,Ltd. It has a market capitalization of just CN¥4.6b, and insiders have CN¥526m worth of shares in their own names. It is great to see insiders so invested in the business. It might be worth checking if those insiders have been buying recently.

我們的信息顯示,內部人士持有大名光學化學股份有限公司的大量股份。它的市值僅爲46億人民幣,內部人士自有的股票價值爲52600萬元。看到內部人士對業務非常投入是一件好事。或許值得查看內部人士最近是否一直在買入。

General Public Ownership

一般大衆所有權

The general public, who are usually individual investors, hold a 45% stake in Daoming Optics&ChemicalLtd. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

一般公衆通常是個人投資者,持有大名光學化學股份有限公司45%的股份。雖然擁有如此規模的持股比例相當可觀,但如果決策與其他大股東不一致,就可能無法改變公司的政策。

Private Equity Ownership

股權投資公司持有8.8%的股份,有能力參與塑造以價值創造爲重點的公司策略。一些投資者可能會因此而受到鼓舞,因爲股權投資公司有時可以鼓勵市場看到公司的價值,從而採取有益的策略。另外,那些持有者可能在將其上市後退出投資。

With a stake of 40%, private equity firms could influence the Daoming Optics&ChemicalLtd board. Some might like this, because private equity are sometimes activists who hold management accountable. But other times, private equity is selling out, having taking the company public.

私募股權投資公司持有40%的股權,可以對Daoming Optics&Chemical Ltd的董事會產生影響。有些人可能喜歡這樣,因爲私募股權投資有時是激進分子,可以追責管理層。但也有時候,私募股權投資會賣出股權,將公司上市。

Next Steps:

下一步:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. Be aware that Daoming Optics&ChemicalLtd is showing 4 warning signs in our investment analysis , and 1 of those is significant...

雖然考慮擁有公司的不同群體是很值得的,但還有其他更重要的因素。請注意,Daoming Optics&Chemical Ltd在我們的投資分析中顯示了4個警示信號,其中一個是重要的...

Of course this may not be the best stock to buy. Therefore, you may wish to see our free collection of interesting prospects boasting favorable financials.

當然,這也可能不是最好的股票交易。因此,您可能想看看我們免費的潛力股票收藏,這些股票具有有利的財務狀況。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論